The Treatment of Poor Risk Nonseminomatous Testicular Tumors
- 1 March 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 131 (3) , 494-496
- https://doi.org/10.1016/s0022-5347(17)50464-4
Abstract
A total of 14 patients with nonseminomatous testicular tumors presenting with characteristics indicative of a poor prognosis were treated with cytoreductive chemotherapy, surgery and immediate reinduction chemotherapy. Of the 14 patients, 12 presently are alive without evidence of disease (median follow-up 18 mo.). This new approach has improved significantly the outcome of these patients.This publication has 7 references indexed in Scilit:
- Treatment of poor prognosis nonseminomatous testicular cancer with a “high-dose” platinum combination chemotherapy regimenCancer, 1983
- The Role of Surgery Following Chemotherapy in Stage III Germ Cell NeoplasmsJournal of Urology, 1982
- Role of chemotherapy and surgery in the treatment of thoracic metastases from nonseminomatous germ cell testis tumorCancer, 1982
- Advanced Metastatic Testicular Cancer: The Need for Reporting Results According to Initial Extent of DiseaseJournal of Urology, 1982
- Distribution of Nodal Metastases in Nonseminomatous Testis CancerJournal of Urology, 1982
- Adjuvant chemotherapy with VAB-3 of stage II-B testicular cancerCancer, 1981
- Cytoreductive Surgery for Metastatic Testis Cancer: Considerations of Timing and ExtentJournal of Urology, 1980